Skip to Main Content

07.18.13

Safety and efficacy of electronic cigarettes to quit smoking are not scientifically demonstrated says WHO – A clear answer to a (not so) complicated problem?

By O’Neill Institute

This post was written by Florian Kastler (Global Health LL.M. 2011), visiting researcher at Georgetown University Law Center. Any comments or questions about this post can be directed to florian.kastler@gmail.com. Last week, on 9 July 2013, the World Health Organization (WHO) updated its Questions and answers on electronic cigarettes or electronic nicotine delivery systems (ENDS) […]

Categories:
Thematic Areas:

07.17.13

Industry Trumps Evidence in Tobacco Packaging U-Turn

By O’Neill Institute

This post was written by Holly Jarman, Research Assistant Professor at the University of Michigan.  For more information about this post, please contact hjarman@umich.edu. The original post can be found at the Huffington Post. The government’s disappointing U-turn over plain packaging of tobacco has dealt a blow to campaigners and shows a government attempting to […]

Categories:
Thematic Areas:

07.10.13

Can new FDA graphic warning labels for tobacco pass a first amendment legal challenge?

By O’Neill Institute

A Georgetown public health expert and attorney examines what the FDA must do to prevail. WASHINGTON — When the U.S. Food and Drug Administration (FDA) imposes new graphic warning labels for tobacco products, they can survive a First Amendment challenge if they depict health consequences and their effectiveness is supported by adequate scientific evidence, says […]

Categories:
Thematic Areas:

07.03.13

Recent World Health Organization (WHO) Study Shows Efficacy of Tobacco Control Laws

By O’Neill Institute

This post was written by Belen Rios, Research Assistant, Global Health LL.M. ‘13, at the O’Neill Institute for National and Global Health Law. Any questions or comments about this post can be directed to mbr55@georgetown.edu. A recent study published by the World Health Organization (WHO) has shown that the adoption of tobacco control laws around the […]

Categories:
Thematic Areas:

06.27.13

Nudging one’s way to a healthy lifestyle – A look at regulations in health through the lens of behavioral economics

By O’Neill Institute

This post was written by Mengyi Xu, O’Neill Institute Summer Intern, Princeton University ’14.  Any comments or questions about this post can be directed to mxu@princeton.edu. To regulate or not to regulate, that is always the question. On the opening day of the O’Neill Institute’s Summer Program on NCDs and law, Professor Alberto Alemanno from HEC […]

Categories:
Thematic Areas:

06.25.13

The AMA Recognizes Obesity as a Disease – Why the controversy surrounding this decision is missing the point and why this decision is the good one?

By O’Neill Institute

This post was written by Florian Kastler (Global Health LL.M. 2011), visiting researcher at Georgetown University Law Center. Any comments or questions about this post can be directed to florian.kastler@gmail.com. By a decision overriding its own council on Science and Public Health, the house of delegates of the American Medical Association (AMA) has officially recognized […]

Categories:
Thematic Areas:

06.21.13

The End of “Pay-for-Delay”? By Opening Collusive Pharmaceutical Settlements to Antitrust Scrutiny, FTC v. Actavis Promises to Make Medicines More Affordable

By Daniel Hougendobler

  In a decision that could save U.S. consumers and taxpayers billions of dollars a year, the Supreme Court ruled Monday that “pay-for-delay,” also known as “reverse payment” settlements, between name-brand and generics pharmaceutical companies are subject to antitrust laws. The seeds of the controversy were planted in 1984 with the passage of the Hatch-Waxman […]

Thematic Areas:

06.14.13

Lessons from the Industry

By Susan C. Kim

In her opening remarks to the 8th Global Conference on Health Promotion, Margaret Chan, Director General of the World Health Organization (WHO) warned: [e]fforts to prevent non-communicable diseases go against the business interests of powerful economic operators. In my view, this is one of the biggest challenges facing health promotion . . . [i]t is […]

Thematic Areas:

06.12.13

Health Privacy Summit

By O’Neill Institute

On June 5 and 6 the O’Neill Institute for National and Global Health Law and Patient Privacy Rights co-hosted a two-day health privacy summit on the Georgetown University Law Center campus. This year’s discussions included the challenges of ensuring personal control over health information in the face of rapid global deployment of healthcare IT and […]

Categories:
Thematic Areas:

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.